Taken together these results, to suppress the effector functions of CD8+ T cells, GCs with high cDC1 evolve into cancer cells with enhanced suppressive functions, such as upregulation of ICP and oncogenic pathways responsible for tolerance maintenance and immune evasion, which are likely used by tumor cells to promote survival. This evidence concerns the gene CD8A and cancer.